| Product Code: ETC13117690 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Zambia continued to rely on imports for pneumococcal vaccines, with top exporting countries being South Africa, India, Canada, USA, and Czech Republic. The Herfindahl-Hirschman Index (HHI) indicated a high concentration of imports. Despite a significant negative compound annual growth rate (CAGR) of -57.5% from 2020 to 2024, there was a slight improvement in the growth rate from 2023 to 2024 at -46.72%. This data suggests a challenging market landscape for pneumococcal vaccine importers in Zambia, urging for strategic planning and market diversification efforts.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Pneumococcal Vaccines Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Zambia Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Zambia Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Zambia Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Zambia Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Zambia Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Zambia Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for vaccination programs |
4.2.2 Rising awareness about the importance of pneumococcal vaccines in preventing diseases |
4.2.3 Growing focus on improving healthcare infrastructure and access to vaccines in Zambia |
4.3 Market Restraints |
4.3.1 Limited healthcare resources and infrastructure in remote areas of Zambia |
4.3.2 High costs associated with the procurement and distribution of pneumococcal vaccines |
5 Zambia Pneumococcal Vaccines Market Trends |
6 Zambia Pneumococcal Vaccines Market, By Types |
6.1 Zambia Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Zambia Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Zambia Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Zambia Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Zambia Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Zambia Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Zambia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Zambia Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Zambia Pneumococcal Vaccines Market Export to Major Countries |
7.2 Zambia Pneumococcal Vaccines Market Imports from Major Countries |
8 Zambia Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate among vulnerable populations |
8.2 Number of healthcare facilities equipped to administer pneumococcal vaccines |
8.3 Percentage of children receiving recommended doses of pneumococcal vaccines |
8.4 Rate of vaccine-preventable diseases in Zambia |
8.5 Awareness level about pneumococcal vaccines among healthcare professionals and the general public |
9 Zambia Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Zambia Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Zambia Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Zambia Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Zambia Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Zambia Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Zambia Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Zambia Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here